查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1701310

临床试验用品市场规模、份额、趋势分析报告：按临床阶段、产品/服务、最终用途、治疗领域、地区、细分预测，2025-2030 年

Clinical Trial Supplies Market Size, Share & Trends Analysis Report By Clinical Phase (Phase I, Phase II, Phase III), By Product & Services, By End Use, By Therapeutic Area, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

临床试验用品市场的成长与趋势：

根据Grand View Research, Inc.的最新报告，全球临床试验用品市场规模预计到2030年将达到41亿美元，预计2025年至2030年期间的复合年增长率为7.19%。

临床试验数量的增加和试验进行的复杂性的增加是推动市场成长的主要因素。

在全球范围内，慢性病盛行率的上升和人口老化的快速发展预计将推动生技药品研发的成长，进一步推动对高效临床用品的需求，并促进临床试验用品行业的成长。此外，对孤儿药的需求不断增长以及对罕见疾病研发的高投入预计也将有助于生物製药的发展。由于这些因素，该领域在预测期内可能会显着增长。

例如，2022年，诺华在研发方面投资约100亿美元。该公司还在欧盟、日本、中国和美国获得了23项新药和罕见疾病药物的核准。此外，该公司在印度拥有 17 个临床项目和 44 个正在进行的 III 期项目，针对非典型溶血性尿毒症综合症 (aHUS)、免疫性血小板缺乏紫斑症(ITP)、脊髓性肌肉萎缩症 (SMA) 和狼疮性肾炎等罕见疾病。

直接面向患者（DTP）预计将成为未来临床试验药物的分销模式。 DTP是一种将药物直接送到患者手中，并进行以患者为中心的临床实验的新兴模式。这将减少访问临床实验地点的次数并减轻参与者的负担。 COVID-19 疫情促使人们更多地采用此类模型，以尽量减少干扰，并继续进行临床试验研究。此外，患者保留率和全球多样化的患者群是该模式采用率高的一些显着原因。

临床试验用品市场报告重点

  • 根据临床阶段，预计市场将以 III 期试验为主导，占 2024 年收入份额的 53.03%。目前处于 III 期试验的分子数量众多是导致这种下降的主要原因。
  • 在服务中，预计储存和配送部门成长最快，预测期内复合年增长率为 7.54%。全球生技药品管道的不断增长以及温度敏感药物的增加预计将增加临床试验药物物流的复杂性。
  • 由于遗传学和生物技术研究的不断增加，例如基于奈米颗粒的药物输送系统的开发，预计生技药品在预测期内将以 7.48% 的最快复合年增长率增长。
  • 在治疗应用方面，肿瘤学占据市场主导地位，2024 年的收入份额为 39.59%。根据合众国际社报道，由于管理不当，美国医院浪费了数十亿管瓶抗癌药，凸显了适当的供应管理的必要性。

目录

第一章调查方法与范围

第二章执行摘要

第三章临床试验用品市场变数、趋势与范围

  • 市场展望
    • 母市场展望
    • 相关/支持市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 技术进步
    • 人工智慧与数位科技的融合
  • 定价模式分析
  • 2024年临床试验量分析
    • 各地区临床试验总数（2024年）
    • 各阶段临床试验总数（2024 年）
    • 依研究设计分类的临床试验总数（2024 年）
    • 按主要治疗领域分類的临床试验总数（2024 年）
  • 市场分析工具
    • 波特五力分析
    • PESTEL 与 SWOT 分析
    • COVID-19影响分析

第四章：临床试验用品市场：依临床阶段的估计与趋势分析

  • 临床试验用品市场（依临床阶段）：细分仪表板
  • 临床试验用品市场（依临床阶段）：波动分析
  • 依临床阶段划分，2018-2030 年
  • 第一阶段
  • 第二阶段
  • 第三阶段
  • 其他的

第五章：临床试验用品市场：依产品和服务的估计和趋势分析

  • 临床试验用品市场（按产品/服务）：细分仪表板
  • 临床试验用品市场（按产品/服务）：变化分析
  • 按产品/服务，2018-2030 年
  • 製造业
    • 2018-2030年临床试验供应製造市场估计与细分预测
    • 储存和运输
    • 供应链管理

第六章临床试验用品市场：按治疗领域分類的估计和趋势

  • 临床试验用品市场（按治疗领域）：细分仪表板
  • 按治疗领域分類的临床试验用品市场：变化分析
  • 依治疗领域，2018-2030年
  • 肿瘤学
  • 中枢神经系统疾病
  • 心血管疾病
  • 感染疾病
  • 代谢紊乱
  • 其他的

第七章临床试验用品市场：依最终用途的估计和趋势分析

  • 临床试验用品市场（依最终用途）：细分仪表板
  • 临床试验用品市场（依最终用途划分）：变化分析
  • 按应用，2018-2030 年
  • 製药
  • 生物製药
  • 医疗设备
  • 其他的

第 8 章：临床试验用品市场：区域估计与趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概况
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章竞争格局

  • 公司分类
    • 市场领导
    • 新兴企业
  • 公司简介
    • Almac Group
    • Biocair
    • Catalent, Inc.
    • KLIFO
    • Movianto
    • PCI Pharma Services
    • Sharp Services, LLC
    • Thermo Fisher Scientific, Inc.
    • UPS Healthcare
    • Paraxel International Corporation
Product Code: GVR-1-68038-514-4

Clinical Trial Supplies Market Growth & Trends:

The global clinical trial supplies market size is estimated to reach USD 4.10 billion in 2030 and is anticipated to grow at a compound annual growth rate CAGR of 7.19% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing volume of clinical trial studies coupled with the growing complexity in conduction of these trials are some of the major factors driving the market growth.

Globally, an increase in the prevalence of chronic diseases and the rapidly aging population are expected to drive the growth of R&D of biologics, which is expected to further propel the demand for efficient clinical supplies and contribute to the growth of the clinical trial supplies industry. Furthermore, an increase in the demand for orphan drugs and high investment in the R&D of rare diseases are also expected to contribute toward the development of biologic drugs. Thus, owing to these factors, this segment is likely to witness significant growth during the forecast period.

For instance, in 2022, Novartis invested around USD 10 billion in research and development. It also secured 23 approvals in the European Union, Japan, China, and the U.S. for new drugs and rare diseases. The company is also conducting 44 ongoing phase III programs in India with 17 clinical programs running in rare diseases such as atypical hemolytic uremic syndrome (aHUS), Immune thrombocytopenic purpura (ITP), spinal muscular atrophy (SMA), and Lupus Nephritis.

Direct-to-Patients (DTP) is an upcoming segment in the distribution of clinical trial supplies, which is expected to be the future model of distribution. DTP is one of the emerging models that involves delivering drugs to patients directly to create patient-centric trials. This would facilitate fewer visits to the site and reduce the burden on participants. The COVID-19 outbreak has led to the increased adoption of such a model, to continue clinical trial studies with minimum disruption. In addition, patient retention and a diverse pool of patients worldwide are some of the notable reasons that can be attributed to the high adoption of this model.

Clinical Trial Supplies Market Report Highlights:

  • Based on the clinical phase, the market is anticipated to be dominated by the Phase III trial segment with a 53.03% revenue share in 2024. The presence of a large number of molecules currently under Phase III makes it the primary factor responsible for this deduction
  • Among services, the storage, and distribution segment is anticipated to witness the fastest growth at a CAGR of 7.54% during the forecast period. The rise in global biologics pipeline and temperature-sensitive drugs is expected to increase the complexities related to the logistics of clinical trial supplies
  • Biologics are expected to witness the fastest growth at 7.48% CAGR during the forecast period owing to the increasing research in the field of genetics and biotechnology such as the development of nanoparticle-based drug delivery systems
  • In terms of therapeutic use, oncology dominated the market with a revenue share of 39.59% in 2024. According to the United Press International, hospitals in the U.S. are disposing of billions of cancer drug vials due to improper dosage, thereby indicating the need for appropriate supply management

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Regional Scope
    • 1.1.2. Estimates and Forecast Timeline
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Purchased Database
    • 1.3.3. GVR's Internal Database
    • 1.3.4. Secondary Sources
    • 1.3.5. Primary Research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Validation
    • 1.5.1. Region Wise Market: Base Estimates
    • 1.5.2. Global Market: CAGR Calculation
  • 1.6. Model Details
    • 1.6.1. Commodity Flow Analysis (Model 1)
    • 1.6.2. Value-Chain-Based Sizing & Forecasting (Model 2)
    • 1.6.3. QFD Model Sizing & Forecasting (Model 3)
    • 1.6.4. Bottom-Up Approach (Model 4)
  • 1.7. List of Secondary Sources
  • 1.8. List of Abbreviations
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Regulatory Framework

Chapter 3. Clinical Trial Supplies Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Expansion of Clinical Trials Sites
      • 3.2.1.2. Growing R&D in Biologics and Biosimilars
      • 3.2.1.3. Advancements in Supply Chain Technology
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. Presence of Stringent Regulatory Policies
      • 3.2.2.2. High Possibility of Counterfeiting Drugs
  • 3.3. Technological Advancements
    • 3.3.1. Integration of AI and Digital Technologies
  • 3.4. Pricing Model Analysis
  • 3.5. Clinical Trials Volume Analysis, 2024
    • 3.5.1. Total Number of Clinical Trials, by Region (2024)
    • 3.5.2. Total Number of Clinical Trials, by Phase (2024)
    • 3.5.3. Total Number of Clinical Trials, by Study Design (2024)
    • 3.5.4. Total Number of Clinical Trials, by Key Therapeutic Area (2024)
  • 3.6. Market Analysis Tools
    • 3.6.1. Porter's Five Forces Analysis
    • 3.6.2. PESTEL by SWOT Analysis
    • 3.6.3. COVID-19 Impact Analysis

Chapter 4. Clinical Trial Supplies Market: Clinical Phase Estimates & Trend Analysis

  • 4.1. Clinical Trial Supplies Market, By Clinical Phase: Segment Dashboard
  • 4.2. Clinical Trial Supplies Market, By Clinical Phase: Movement Analysis
  • 4.3. Clinical Trial Supplies Market Estimates & Forecasts, By Clinical Phase, 2018 - 2030 (USD Million)
  • 4.4. Phase I
    • 4.4.1. Phase I Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Phase II
    • 4.5.1. Phase II Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Phase III
    • 4.6.1. Phase III Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Clinical Trial Supplies Market: Product & Service Estimates & Trend Analysis

  • 5.1. Clinical Trial Supplies Market, By Product & Service: Segment Dashboard
  • 5.2. Clinical Trial Supplies Market, By Product & Service: Movement Analysis
  • 5.3. Clinical Trial Supplies Market Estimates & Forecasts, By Product & Service, 2018 - 2030 (USD Million)
  • 5.4. Manufacturing
    • 5.4.1. Manufacturing Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. Storage & Distribution
      • 5.4.2.1. Downstream processing Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
      • 5.4.2.2. Cold Chain Distribution
        • 5.4.2.2.1. Cold Chain Distribution Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
      • 5.4.2.3. Non-Cold Chain Distribution
        • 5.4.2.3.1. Non-Cold Chain Distribution Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. Supply Chain Management
      • 5.4.3.1. Supply Chain Management Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Clinical Trial Supplies Market: Therapeutic Area Estimates & Trend Analysis

  • 6.1. Clinical Trial Supplies Market, By Therapeutic Area: Segment Dashboard
  • 6.2. Clinical Trial Supplies Market, By Therapeutic Area: Movement Analysis
  • 6.3. Clinical Trial Supplies Market Estimates & Forecasts, By Therapeutic Area, 2018 - 2030 (USD Million)
  • 6.4. Oncology
    • 6.4.1. Oncology Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
  • 6.5. CNS Diseases
    • 6.5.1. CNS Diseases Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Cardiovascular Diseases
    • 6.6.1. Cardiovascular Diseases Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Infectious Disease
    • 6.7.1. Infectious Disease Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Metabolic Disorders
    • 6.8.1. Metabolic Disorders Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
  • 6.9. Others
    • 6.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Clinical Trial Supplies Market: End Use Estimates & Trend Analysis

  • 7.1. Clinical Trial Supplies Market, By End Use: Segment Dashboard
  • 7.2. Clinical Trial Supplies Market, By End Use: Movement Analysis
  • 7.3. Clinical Trial Supplies Market Estimates & Forecasts, By End Use, 2018 - 2030 (USD Million)
  • 7.4. Pharmaceutical
    • 7.4.1. Pharmaceutical Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Biologics
    • 7.5.1. Oncology Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Medical Devices
    • 7.6.1. Medical Devices Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Others
    • 7.7.1. Others Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Clinical Trial Supplies Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2024 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Global Regional Market Snapshot
  • 8.4. North America
    • 8.4.1. North America Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. U.S. Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Canada Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Mexico Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. UK Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Germany Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. France Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Italy Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Spain Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. Denmark
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. Denmark Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.8. Sweden
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Competitive Scenario
      • 8.5.8.3. Regulatory Framework
      • 8.5.8.4. Sweden Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.9. Norway
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Competitive Scenario
      • 8.5.9.3. Regulatory Framework
      • 8.5.9.4. Norway Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. China
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. China Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. Japan
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Japan Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. India Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. Australia
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Competitive Scenario
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Australia Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.6. South Korea
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Competitive Scenario
      • 8.6.6.3. Regulatory Framework
      • 8.6.6.4. South Korea Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Competitive Scenario
      • 8.6.7.3. Regulatory Framework
      • 8.6.7.4. Thailand Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. Brazil Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Argentina Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8. Middle East and Africa
    • 8.8.1. Middle East and Africa Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Competitive Scenario
      • 8.8.2.3. Regulatory Framework
      • 8.8.2.4. South Africa Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Competitive Scenario
      • 8.8.3.3. Regulatory Framework
      • 8.8.3.4. Saudi Arabia Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Competitive Scenario
      • 8.8.4.3. Regulatory Framework
      • 8.8.4.4. UAE Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Competitive Scenario
      • 8.8.5.3. Regulatory Framework
      • 8.8.5.4. Kuwait Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
    • 9.1.1. Market Leaders
    • 9.1.2. Emerging Players
  • 9.2. Company Profiles
    • 9.2.1. Almac Group
      • 9.2.1.1. Participant's Overview
      • 9.2.1.2. Financial Performance
      • 9.2.1.3. Service Benchmarking
      • 9.2.1.4. Strategic Initiatives
    • 9.2.2. Biocair
      • 9.2.2.1. Participant's Overview
      • 9.2.2.2. Financial Performance
      • 9.2.2.3. Service Benchmarking
      • 9.2.2.4. Strategic Initiatives
    • 9.2.3. Catalent, Inc.
      • 9.2.3.1. Participant's Overview
      • 9.2.3.2. Financial Performance
      • 9.2.3.3. Service Benchmarking
      • 9.2.3.4. Strategic Initiatives
    • 9.2.4. KLIFO
      • 9.2.4.1. Participant's Overview
      • 9.2.4.2. Financial Performance
      • 9.2.4.3. Service Benchmarking
      • 9.2.4.4. Strategic Initiatives
    • 9.2.5. Movianto
      • 9.2.5.1. Participant's Overview
      • 9.2.5.2. Financial Performance
      • 9.2.5.3. Service Benchmarking
      • 9.2.5.4. Strategic Initiatives
    • 9.2.6. PCI Pharma Services
      • 9.2.6.1. Participant's Overview
      • 9.2.6.2. Financial Performance
      • 9.2.6.3. Service Benchmarking
      • 9.2.6.4. Strategic Initiatives
    • 9.2.7. Sharp Services, LLC
      • 9.2.7.1. Participant's Overview
      • 9.2.7.2. Financial Performance
      • 9.2.7.3. Service Benchmarking
      • 9.2.7.4. Strategic Initiatives
    • 9.2.8. Thermo Fisher Scientific, Inc.
      • 9.2.8.1. Participant's Overview
      • 9.2.8.2. Financial Performance
      • 9.2.8.3. Service Benchmarking
      • 9.2.8.4. Strategic Initiatives
    • 9.2.9. UPS Healthcare
      • 9.2.9.1. Participant's Overview
      • 9.2.9.2. Financial Performance
      • 9.2.9.3. Service Benchmarking
      • 9.2.9.4. Strategic Initiatives
    • 9.2.10. Paraxel International Corporation
      • 9.2.10.1. Participant's Overview
      • 9.2.10.2. Financial Performance
      • 9.2.10.3. Service Benchmarking
      • 9.2.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 4 Global Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 5 Global Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 6 Global Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 7 Global Clinical Trials Supplies Market, by Region, 2018 - 2030 (USD Million)
  • Table 8 North America Clinical Trials Supplies Market, by Country, 2018 - 2030 (USD Million)
  • Table 9 North America Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 10 North America Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 11 North America Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 12 North America Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 13 U.S. Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 14 U.S. Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 15 U.S. Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 16 U.S. Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 17 Canada Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 18 Canada Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 19 Canada Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 20 Canada Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 21 Mexico Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 22 Mexico Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 23 Mexico Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 24 Mexico Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 25 Europe Clinical Trials Supplies Market, by Country, 2018 - 2030 (USD Million)
  • Table 26 Europe Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 27 Europe Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 28 Europe Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 29 Europe Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 30 Germany Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 31 Germany Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 32 Germany Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 33 Germany Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 34 UK Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 35 UK Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 36 UK Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 37 UK Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 38 France Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 39 France Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 40 France Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 41 France Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 42 Italy Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 43 Italy Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 44 Italy Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 45 Italy Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 46 Spain Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 47 Spain Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 48 Spain Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 49 Spain Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 50 Denmark Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 51 Denmark Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 52 Denmark Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 53 Denmark Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 54 Sweden Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 55 Sweden Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 56 Sweden Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 57 Sweden Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 58 Norway Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 59 Norway Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 60 Norway Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 61 Norway Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Clinical Trials Supplies Market, by Country, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 67 China Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 68 China Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 69 China Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 70 China Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 71 Japan Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 72 Japan Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 73 Japan Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 74 Japan Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 75 India Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 76 India Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 77 India Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 78 India Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 79 South Korea Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 80 South Korea Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 81 South Korea Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 82 South Korea Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 83 Australia Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 84 Australia Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 85 Australia Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 86 Australia Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 87 Thailand Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 88 Thailand Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 89 Thailand Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 90 Thailand Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 91 Latin America Clinical Trials Supplies Market, by Country, 2018 - 2030 (USD Million)
  • Table 92 Latin America Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 93 Latin America Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 94 Latin America Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 95 Latin America Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 96 Brazil Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 97 Brazil Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 98 Brazil Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 99 Brazil Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 100 Argentina Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 101 Argentina Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 102 Argentina Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 103 Argentina Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 104 Middle East & Africa Clinical Trials Supplies Market, by Country, 2018 - 2030 (USD Million)
  • Table 105 Middle East & Africa Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 106 Middle East & Africa Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 107 Middle East & Africa Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 108 Middle East & Africa Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 109 South Africa Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 110 South Africa Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 111 South Africa Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 112 South Africa Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 117 UAE Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 118 UAE Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 119 UAE Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 120 UAE Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 121 Kuwait Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 122 Kuwait Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 123 Kuwait Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 124 Kuwait Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Clinical Trial Supplies, Market Segmentation
  • Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Regional Marketplace: Key Takeaways
  • Fig. 12 Global Clinical Trial Supplies, for Phase I, 2018 - 2030 (USD Million)
  • Fig. 13 Global Clinical Trial Supplies, for Phase II, 2018 - 2030 (USD Million)
  • Fig. 14 Global Clinical Trial Supplies, for Phase III, 2018 - 2030 (USD Million)
  • Fig. 15 Global Clinical Trial Supplies, for Others, 2018 - 2030 (USD Million)
  • Fig. 16 Global Clinical Trial Supplies, for Manufacturing, 2018 - 2030 (USD Million)
  • Fig. 17 Global Clinical Trial Supplies, for Cold Chain Distribution, 2018 - 2030 (USD Million)
  • Fig. 18 Global Clinical Trial Supplies, for Non-cold Chain, 2018 - 2030 (USD Million)
  • Fig. 19 Global Clinical Trial Supplies, for Storage & Distribution, 2018 - 2030 (USD Million)
  • Fig. 20 Global Clinical Trial Supplies, for Supply Chain Management, 2018 - 2030 (USD Million)
  • Fig. 21 Global Clinical Trial Supplies, for Pharmaceutical, 2018 - 2030 (USD Million)
  • Fig. 22 Global Clinical Trial Supplies, for Biologics, 2018 - 2030 (USD Million)
  • Fig. 23 Global Clinical Trial Supplies for Medical Device, 2018 - 2030 (USD Million)
  • Fig. 24 Global Clinical Trial Supplies, for Others, 2018 - 2030 (USD Million)
  • Fig. 25 Global Clinical Trial Supplies, for Oncology, 2018 - 2030 (USD Million)
  • Fig. 26 Global Clinical Trial Supplies, for CNS Diseases, 2018 - 2030 (USD Million)
  • Fig. 27 Global Clinical Trial Supplies, for Cardiovascular Diseases, 2018 - 2030 (USD Million)
  • Fig. 28 Global Clinical Trial Supplies, for Infectious Disease, 2018 - 2030 (USD Million)
  • Fig. 29 Global Clinical Trial Supplies, for Metabolic Disorders, 2018 - 2030 (USD Million)
  • Fig. 30 Global Clinical Trial Supplies, for Others, 2018 - 2030 (USD Million)
  • Fig. 31 Regional Outlook, 2024 & 2030
  • Fig. 32 North America Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Canada Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Mexico Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Europe Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 UK Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Germany Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 France Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Italy Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Spain Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Denmark Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Sweden Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Norway Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Asia Pacific Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 India Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 China Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Japan Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 South Korea Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Australia Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Thailand Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Latin America Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Brazil Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Argentina Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 MEA Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 South Africa Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Saudi Arabia Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 UAE Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Kuwait Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)